Your browser doesn't support javascript.
loading
[Additional possible mechanisms of the action of ocrelizumab in multiple sclerosis on example of a case-report]. / Vozmozhnye dopolnitel'nye mekhanizmy deistviia okrelizumaba pri rasseiannom skleroze na primere klinicheskogo sluchaia.
Boyko, O V; Khoroshylova, I I; Petrov, S V; Lush, N Yu; Guseva, M E; Boyko, A N.
Affiliation
  • Boyko OV; Pirogov Russian National Research Medical University, Moscow, Russia; OOO 'Neuroclinica', Moscow, Russia.
  • Khoroshylova II; OOO 'Neuroclinica', Moscow, Russia.
  • Petrov SV; OOO 'Neuroclinica', Moscow, Russia.
  • Lush NY; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Guseva ME; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia; OOO 'Neuroclinica', Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova ; 118(8. Vyp. 2): 116-120, 2018.
Article de Ru | MEDLINE | ID: mdl-30160679

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anticorps monoclonaux humanisés / Sclérose en plaques Limites: Humans Langue: Ru Journal: Zh Nevrol Psikhiatr Im S S Korsakova Sujet du journal: NEUROLOGIA / PSIQUIATRIA Année: 2018 Type de document: Article Pays d'affiliation: Russie Pays de publication: Russie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anticorps monoclonaux humanisés / Sclérose en plaques Limites: Humans Langue: Ru Journal: Zh Nevrol Psikhiatr Im S S Korsakova Sujet du journal: NEUROLOGIA / PSIQUIATRIA Année: 2018 Type de document: Article Pays d'affiliation: Russie Pays de publication: Russie